CorrectionErratum
Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
Kenan Zhang, Xing Liu, Guanzhang Li, Xin Chang, Shouwei Li, Jing Chen, Zheng Zhao, Jiguang Wang, Tao Jiang and Ruichao Chai
Cancer Biology & Medicine July 2023, 20 (7) 537; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0227
Kenan Zhang
1Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
Xing Liu
2Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
Guanzhang Li
1Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
3Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
Xin Chang
4Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China
Shouwei Li
4Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China
Jing Chen
1Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
Zheng Zhao
1Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
Jiguang Wang
5Division of Life Science and State Key Laboratory of Molecular Neuroscience, Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR 999077, China
6Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong SAR 999077, China
7HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute, Futian, Shenzhen 518057, China
Tao Jiang
1Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
3Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
Ruichao Chai
1Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
2Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
5Division of Life Science and State Key Laboratory of Molecular Neuroscience, Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR 999077, China

Reference
- 1.↵
- Zhang K,
- Liu X,
- Li G,
- Chang X,
- Li S,
- Chen J, et al.
In this issue
Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
Kenan Zhang, Xing Liu, Guanzhang Li, Xin Chang, Shouwei Li, Jing Chen, Zheng Zhao, Jiguang Wang, Tao Jiang, Ruichao Chai
Cancer Biology & Medicine Jul 2023, 20 (7) 537; DOI: 10.20892/j.issn.2095-3941.2023.0227
Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
Kenan Zhang, Xing Liu, Guanzhang Li, Xin Chang, Shouwei Li, Jing Chen, Zheng Zhao, Jiguang Wang, Tao Jiang, Ruichao Chai
Cancer Biology & Medicine Jul 2023, 20 (7) 537; DOI: 10.20892/j.issn.2095-3941.2023.0227
Jump to section
Related Articles
Cited By...
- No citing articles found.